Published in Neurol Sci on November 01, 2010
Neuroplasticity and functional recovery in multiple sclerosis. Nat Rev Neurol (2012) 0.93
Neuropsychology of multiple sclerosis: a critical review. J Clin Exp Neuropsychol (1986) 2.02
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol (2008) 1.75
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol (2007) 1.73
Rehabilitation of executive functioning: an experimental-clinical validation of goal management training. J Int Neuropsychol Soc (2000) 1.58
Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc (2002) 1.27
Cognitive changes in multiple sclerosis. Expert Rev Neurother (2008) 1.14
Putting the pieces together: preliminary efficacy of a family problem-solving intervention for children with traumatic brain injury. J Head Trauma Rehabil (2006) 1.07
Reducing everyday memory and planning problems by means of a paging system: a randomised control crossover study. J Neurol Neurosurg Psychiatry (2001) 1.06
Effectiveness of an attention-training program. J Clin Exp Neuropsychol (1987) 1.06
Beneficial effect from a cognitive training programme on children with acquired brain injuries demonstrated in a controlled study. Brain Inj (2005) 0.91
Direct clinician-delivered versus indirect family-supported rehabilitation of children with traumatic brain injury: a randomized controlled trial. Brain Inj (2005) 0.90
The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis. Mult Scler (2009) 0.88
Cognitive rehabilitation for children with acquired brain injury. Dev Disabil Res Rev (2009) 0.80
Memory strategy training in children with cerebral infarcts related to sickle cell disease. J Pediatr Hematol Oncol (2003) 0.77
New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol (2007) 3.87
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler (2013) 2.20
Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol (2009) 1.88
Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci (2006) 1.81
Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. Neurology (2013) 1.72
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Neurology (2013) 1.61
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler (2010) 1.22
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol (2007) 1.22
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. BMC Neurol (2012) 1.18
Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci (2009) 1.14
Cognitive changes in multiple sclerosis. Expert Rev Neurother (2008) 1.14
The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis. J Neuroimmunol (2005) 1.13
Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS One (2012) 1.12
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS One (2011) 1.05
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLoS One (2012) 1.04
Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score. J Neurol Neurosurg Psychiatry (2007) 1.02
Improving compliance with interferon-beta therapy in patients with multiple sclerosis. CNS Drugs (2009) 1.02
Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler (2009) 0.99
Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol (2006) 0.99
Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment. J Neuroimmunol (2008) 0.97
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. PLoS One (2010) 0.97
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases. Mult Scler (2012) 0.97
The management of multiple sclerosis in children: a European view. Mult Scler (2010) 0.95
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. Mult Scler (2010) 0.94
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. BMC Neurol (2012) 0.94
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent. Ann Neurol (2014) 0.91
Evolving expectations around early management of multiple sclerosis. Ther Adv Neurol Disord (2010) 0.91
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis. PLoS One (2013) 0.89
International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology (2013) 0.89
Relevance of brain lesion location to cognition in relapsing multiple sclerosis. PLoS One (2012) 0.88
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment. J Neurol Sci (2006) 0.87
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. Neurol Sci (2013) 0.87
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. PLoS One (2013) 0.86
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis. Mult Scler (2013) 0.86
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain (2006) 0.86
Are there protective treatments for cognitive decline in MS? J Neurol Sci (2006) 0.85
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience. Neurol Sci (2009) 0.84
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol (2012) 0.84
Changes in neuropsychological test performance over the workday in multiple sclerosis. Clin Neuropsychol (2003) 0.83
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. J Neurol Sci (2006) 0.83
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain (2013) 0.83
Natalizumab: a country-based surveillance program. Neurol Sci (2008) 0.82
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety. J Neurol Sci (2007) 0.82
Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis. Mult Scler (2010) 0.82
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. BMC Neurol (2014) 0.81
Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult Scler (2013) 0.80
Impact of cognitive impairment on coping strategies in multiple sclerosis. Clin Neurol Neurosurg (2009) 0.80
Clinical correlations of CSF single IgG bands. J Neurol (2005) 0.80
Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. Arch Neurol (2004) 0.79
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. J Neuroinflammation (2013) 0.79
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis. Neurology (2014) 0.79
APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Mult Scler (2009) 0.79